|
BBX expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.98150000000541E-05 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.76380000000065E-05 |
| Normal-vs-Stage2 |
8.070200E-02 |
| Normal-vs-Stage3 |
1.740240E-02 |
| Normal-vs-Stage4 |
1.570090E-02 |
| Stage1-vs-Stage2 |
6.660400E-01 |
| Stage1-vs-Stage3 |
7.512400E-01 |
| Stage1-vs-Stage4 |
5.471200E-01 |
| Stage2-vs-Stage3 |
8.875800E-01 |
| Stage2-vs-Stage4 |
4.052400E-01 |
| Stage3-vs-Stage4 |
4.121400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.45089999999704E-05 |
| Normal-vs-AfricanAmerican |
2.455100E-03 |
| Normal-vs-Asian |
1.154230E-02 |
| Caucasian-vs-AfricanAmerican |
9.281000E-01 |
| Caucasian-vs-Asian |
7.748000E-01 |
| AfricanAmerican-vs-Asian |
7.365800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.10670000000412E-07 |
| Normal-vs-Female |
5.765800E-01 |
| Male-vs-Female |
1.244950E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
7.632300E-04 |
| Normal-vs-Extreme_Weight |
1.76090000003626E-06 |
| Normal-vs-Obese |
1.470110E-02 |
| Normal-vs-Extreme_Obese |
5.377700E-02 |
| Normal_Weight-vs-Extreme_Weight |
6.815400E-01 |
| Normal_Weight-vs-Obese |
2.472200E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.484800E-01 |
| Extreme_Weight-vs-Obese |
6.999800E-02 |
| Extreme_Weight-vs-Extreme_Obese |
9.734400E-01 |
| Obese-vs-Extreme_Obese |
3.793800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.072800E-01 |
| Normal-vs-Age(41-60Yrs) |
1.714440E-02 |
| Normal-vs-Age(61-80Yrs) |
9.54650000051238E-07 |
| Normal-vs-Age(81-100Yrs) |
1.607430E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.256000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.274390E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.934300E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.145800E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.437000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.990200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.571500E-04 |
| Normal-VS-Type2 PRCC |
4.78359999944722E-07 |
| Normal-VS-KIRP CIMP |
7.816000E-01 |
| Normal-VS-Unclassified PRCC |
4.282000E-01 |
| Type1 PRCC-VS-Type2 PRCC |
3.689800E-02 |
| Type1 PRCC-VS-KIRP CIMP |
9.856000E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
3.048800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
9.199500E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
3.807600E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
5.416400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.26470000028078E-07 |
| Normal-vs-N1 |
2.357200E-01 |
| Normal-vs-N2 |
2.884800E-01 |
| N0-vs-N1 |
1.076020E-02 |
| N0-vs-N2 |
7.448000E-01 |
| N1-vs-N2 |
4.261400E-01 |
|
|
